Atlas Capital Advisors LLC Invitae Corp Transaction History

Atlas Capital Advisors LLC

  • $788 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$6.28 - $15.59 $18,840 - $46,770
-3,000 Reduced 6.44%
43,581 $347 Million
Q3 2021

Oct 28, 2021
BUY
$24.31 - $33.6 $300,909 - $415,900
12,378 Added 36.19%
46,581 $1.32 Million
Q1 2021

May 10, 2021
BUY
$33.06 - $56.93 $99,180 - $170,790
3,000 Added 9.61%
34,203 $1.31 Million
Q4 2020

Feb 16, 2021
BUY
$39.09 - $57.4 $1.22 Million - $1.79 Million
31,203 New
31,203 $1.3 Million

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email